ACR Appropriateness Criteria® external beam radiation therapy treatment planning for clinically localized prostate cancer, part I of II

Expert Panel on Radiation Oncology-Prostate: Nicholas G. Zaorsky MD , Timothy N. Showalter MD MPH *, Gary A. Ezzell PhD , Paul L. Nguyen MD , Dean G. Assimos MD , Anthony V. D’Amico MD PhD , Alexander R. Gottschalk MD PhD , Gary S. Gustafson MD , Sameer R. Keole MD , Stanley L. Liauw MD , Shane Lloyd MD , Patrick W. McLaughlin MD , Benjamin Movsas MD , Bradley R. Prestidge MD MS , Al V. Taira MD , Neha Vapiwala MD , Brian J. Davis MD PhD q

• Publication year

  2016

• Venue

  Advances in Radiation Oncology

• Publication date

  2016-10-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.adro.2016.10.002PMID 28740916PMCID 5514238
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer statistics, 2015

  2015cited by this paper
• Impact of obesity on outcomes after definitive dose‐escalated intensity‐modulated radiotherapy for localized prostate cancer

  2015influential reference
• Anterior-oriented proton beams for prostate cancer: A multi-institutional experience

  2015cited by this paper
• Stereotactic ultrasound for target volume definition in a patient with prostate cancer and bilateral total hip replacement.

  2015cited by this paper
• Low Toxicity in Inflammatory Bowel Disease Patients Treated With Abdominal and Pelvic Radiation Therapy

  2015cited by this paper
• Evaluating toxicity from definitive radiation therapy for prostate cancer in men with inflammatory bowel disease: Patient selection and dosimetric parameters with modern treatment techniques.

  2015cited by this paper
• Effect of metal hip prosthesis on the accuracy of electromagnetic localization tracking.

  2015cited by this paper
• Dosimetric study of uniform scanning proton therapy planning for prostate cancer patients with a metal hip prosthesis, and comparison with volumetric‐modulated arc therapy

  2014cited by this paper
• Stereotactic Body Radiation Therapy for Prostate Cancer: Review of Experience of a Multicenter Phase I/II Dose-Escalation Study

  2014cited by this paper
• Prostate cancer, version 2.2014.

  2014influential reference
• Metal artifact reduction software used with abdominopelvic dual-energy CT of patients with metal hip prostheses: assessment of image quality and clinical feasibility.

  2014cited by this paper
• Dosimetric implications of an injection of hyaluronic acid for preserving the rectal wall in prostate stereotactic body radiation therapy.

  2014cited by this paper
• Local recurrence map to guide target volume delineation after radical prostatectomy.

  2014cited by this paper
• ACR appropriateness Criteria® Postradical prostatectomy irradiation in prostate cancer.

  2014cited by this paper
• A dosimetric study of volumetric modulated arc therapy planning techniques for treatment of low-risk prostate cancer in patients with bilateral hip prostheses

  2014cited by this paper
• Optimization of tomotherapy treatment planning for patients with bilateral hip prostheses

  2014cited by this paper
• Quality of Life and Toxicity after SBRT for Organ-Confined Prostate Cancer, a 7-Year Study

  2014cited by this paper
• Late toxicity and quality of life after definitive treatment of prostate cancer: redefining optimal rectal sparing constraints for intensity-modulated radiation therapy

  2014cited by this paper
• Systematic review of hypofractionated radiation therapy for prostate cancer.

  2013cited by this paper
• A multi-institutional clinical trial of rectal dose reduction via injected polyethylene-glycol hydrogel during intensity modulated radiation therapy for prostate cancer: analysis of dosimetric outcomes.

  2013cited by this paper
• Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 prostate cancer trial.

  2013cited by this paper
• DEFINITIVE EXTERNAL-BEAM IRRADIATION IN STAGE T1 AND T2 PROSTATE CANCER

  2013cited by this paper
• Implementation of an image guided intensity‐modulated protocol for post‐prostatectomy radiotherapy: Planning data and acute toxicity outcomes

  2013cited by this paper
• Outcomes in men with large prostates (≥ 60 cm3) treated with definitive proton therapy for prostate cancer

  2013cited by this paper
• Prostate hypofractionated radiation therapy: injection of hyaluronic acid to better preserve the rectal wall.

  2013cited by this paper
• Interstitial biodegradable balloon for reduced rectal dose during prostate radiotherapy: results of a virtual planning investigation based on the pre- and post-implant imaging data of an international multicenter study.

  2013cited by this paper
• Stereotactic body radiation therapy for prostate cancer: is the technology ready to be the standard of care?

  2013cited by this paper
• Prospective evaluation of a hydrogel spacer for rectal separation in dose-escalated intensity-modulated radiotherapy for clinically localized prostate cancer

  2013cited by this paper
• Application of an interstitial and biodegradable balloon system for prostate-rectum separation during prostate cancer radiotherapy: a prospective multi-center study

  2013cited by this paper
• Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer.

  2013cited by this paper
• Evolution of advanced technologies in prostate cancer radiotherapy

  2013cited by this paper
• Automated generation of IMRT treatment plans for prostate cancer patients with metal hip prostheses: comparison of different planning strategies.

  2013cited by this paper
• Which bowel preparation is best? Comparison of a high-fibre diet leaflet, daily microenema and no preparation in prostate cancer patients treated with radical radiotherapy to assess the effect on planned target volume shifts due to rectal distension.

  2013cited by this paper
• Age and comorbid illness are associated with late rectal toxicity following dose-escalated radiation therapy for prostate cancer.

  2013cited by this paper
• An updated prostate cancer staging nomogram (Partin tables) based on cases from 2006 to 2011

  2013cited by this paper
• Anatomic variation and dosimetric consequences of neoadjuvant hormone therapy before radiation therapy for prostate cancer.

  2013cited by this paper
• Boosting imaging defined dominant prostatic tumors: a systematic review.

  2013cited by this paper
• Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas.

  2012cited by this paper
• Human collagen injections to reduce rectal dose during radiotherapy.

  2012cited by this paper
• Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer.

  2012cited by this paper
• Multiparametric MRI and prostate cancer diagnosis and risk stratification

  2012cited by this paper
• Magnetic resonance imaging in postprostatectomy radiotherapy planning.

  2012cited by this paper
• Comparative toxicity and dosimetric profile of whole-pelvis versus prostate bed-only intensity-modulated radiation therapy after prostatectomy.

  2012cited by this paper
• Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer.

  2012cited by this paper
• Intensity modulated proton and photon therapy for early prostate cancer with or without transperineal injection of a polyethylen glycol spacer: a treatment planning comparison study.

  2012cited by this paper
• Intensity modulated radiation therapy planning for patients with a metal hip prosthesis based on class solutions.

  2012cited by this paper
• Constrained‐beam inverse planning for intensity‐modulated radiation therapy of prostate cancer patients with bilateral hip prostheses

  2012cited by this paper
• Implanted dosimeters identify radiation overdoses during IMRT for prostate cancer.

  2012cited by this paper
• Clinical evaluation of a commercial orthopedic metal artifact reduction tool for CT simulations in radiation therapy.

  2012cited by this paper
• Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT.

  2012cited by this paper
• Stereotactic Body Radiation Therapy for Low, Intermediate, and High-risk Prostate Cancer: Disease Control and Quality of Life

  2011cited by this paper
• Phase I dose-escalation study of stereotactic body radiation therapy for low- and intermediate-risk prostate cancer.

  2011influential reference
• Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study

  2011cited by this paper
• An evaluation of intrafraction motion of the prostate in the prone and supine positions using electromagnetic tracking.

  2011cited by this paper
• A PROSPECTIVE STUDY OF INTRAFRACTION PROSTATE MOTION IN THE PRONE VS. SUPINE POSITION

  2011cited by this paper
• Delineation of the postprostatectomy prostate bed using computed tomography: interobserver variability following the EORTC delineation guidelines.

  2011cited by this paper
• 70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial.

  2011cited by this paper
• Prostate bed motion during intensity-modulated radiotherapy treatment.

  2011cited by this paper
• State of the art on dose prescription, reporting and recording in Intensity-Modulated Radiation Therapy (ICRU report No. 83).

  2011cited by this paper
• ACR Appropriateness Criteria® Definitive External-Beam Irradiation in Stage T1 and T2 Prostate Cancer

  2011cited by this paper
• Application of a spacer gel to optimize three-dimensional conformal and intensity modulated radiotherapy for prostate cancer.

  2011cited by this paper
• Can images obtained with high field strength magnetic resonance imaging reduce contouring variability of the prostate?

  2011cited by this paper
• Megavoltage CT Images of Helical Tomotherapy Unit for Radiation Treatment Simulation: Impact on Feasibility of Treatment Planning in a Prostate Cancer Patient with Bilateral Femoral Prostheses

  2011cited by this paper
• Assessing the daily consistency of bladder filling using an ultrasonic Bladderscan device in men receiving radical conformal radiotherapy for prostate cancer.

  2011cited by this paper
• Advances in magnetic resonance imaging: how they are changing the management of prostate cancer.

  2011cited by this paper
• Post‐prostatectomy image‐guided radiation therapy: Evaluation of toxicity and inter‐fraction variation using online cone‐beam CT

  2011cited by this paper
• A cinematic magnetic resonance imaging study of milk of magnesia laxative and an antiflatulent diet to reduce intrafraction prostate motion.

  2010cited by this paper
• Clinician's guide to prostate IMRT plan assessment and optimisation

  2010cited by this paper
• Clinical application of image-guided radiotherapy in bladder and prostate cancer.

  2010cited by this paper
• Guest editor's introduction to QUANTEC: a users guide.

  2010cited by this paper
• Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09.

  2010cited by this paper
• Cine-Magnetic Resonance Imaging Assessment of Intrafraction Motion for Prostate Cancer Patients Supine or Prone With and Without a Rectal Balloon

  2010cited by this paper
• Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study.

  2010cited by this paper
• Reduction of dose delivered to organs at risk in prostate cancer patients via image-guided radiation therapy.

  2010cited by this paper
• A prospective study of intrafraction prostate motion in the prone vs. supine position.

  2010cited by this paper
• Stereotactic Body Radiotherapy as Boost for Organ-confined Prostate Cancer

  2010cited by this paper
• Time trends and local variation in primary treatment of localized prostate cancer.

  2010cited by this paper
• The current status of image-guided external beam radiotherapy for prostate cancer

  2010cited by this paper
• Effects of prostate-rectum separation on rectal dose from external beam radiotherapy.

  2010cited by this paper
• Postoperative radiotherapy in prostate cancer: the case of the missing target.

  2010cited by this paper
• Radiation dose-volume effects of the urinary bladder.

  2010cited by this paper
• Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer.

  2010cited by this paper
• Prostate and seminal vesicle volume based consideration of prostate cancer patients for treatment with 3D-conformal or intensity-modulated radiation therapy.

  2010cited by this paper
• Radiation dose-volume effects in radiation-induced rectal injury.

  2010cited by this paper
• Radiation dose-volume effects and the penile bulb.

  2010cited by this paper
• Radiographic and anatomic basis for prostate contouring errors and methods to improve prostate contouring accuracy.

  2010cited by this paper
• Is there a role for endorectal balloons in prostate radiotherapy? A systematic review.

  2010influential reference
• Megavoltage CT in Helical Tomotherapy — Clinical Advantages and Limitations of Special Physical Characteristics

  2009cited by this paper
• Using Cone-Beam Computed Tomography to Evaluate the Impact of Bladder Filling Status on Target Position in Prostate Radiotherapy

  2009cited by this paper
• Tradeoffs of integrating real-time tracking into IGRT for prostate cancer treatment

  2009cited by this paper
• Radical prostatectomy vs. intensity-modulated radiation therapy in the management of localized prostate adenocarcinoma.

  2009cited by this paper
• RTOG GU Radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer.

  2009cited by this paper
• Prostate delineation using CT and MRI for radiotherapy patients with bilateral hip prostheses.

  2009cited by this paper
• Dosimetric outcomes in prostate brachytherapy: is downsizing the prostate with androgen deprivation necessary?

  2009cited by this paper
• Outcomes for intermediate risk prostate cancer: are there advantages for surgery, external radiation, or brachytherapy?

  2009cited by this paper
• Potentials of on-line repositioning based on implanted fiducial markers and electronic portal imaging in prostate cancer radiotherapy

  2009cited by this paper
• Functional magnetic resonance imaging in prostate cancer.

  2009cited by this paper
• Anal wall sparing effect of an endorectal balloon in 3D conformal and intensity-modulated prostate radiotherapy.

  2009cited by this paper
• A comprehensive assessment by tumor site of patient setup using daily MVCT imaging from more than 3,800 helical tomotherapy treatments.

  2009cited by this paper
• Dosimetric effects of the prone and supine positions on image guided localized prostate cancer radiotherapy.

  2008cited by this paper

• Risk factors for rectal wall infiltration in hydrogel spacer placement: Influence of biopsy approach

  2025cites this paper
• CHHiP vs PROFIT for Localized Prostate Cancer: A Retrospective Dosimetric Comparison of Organs at Risk

  2024cites this paper
• Bowel and Bladder Reproducibility in Image Guided Radiation Therapy for Prostate Cancer: Results of a Patterns of Practice Survey

  2022cites this paper
• Salvage therapy for prostate cancer after radical prostatectomy

  2021cites this paper
• Clinical Differences Among Volumetric Modulated Arc Therapy, Intensity Modulated Radiation Therapy, and 3D- Conformal Radiation Therapy in Prostate Cancer: A Brief Review Study

  2021cites this paper
• Computer-aided segmentation on MRI for prostate radiotherapy, part II: Comparing human and computer observer populations and the influence of annotator variability on algorithm variability.

  2021cites this paper
• Conventional and Moderately Hypofractionated Radiation Therapy for Prostate Cancer

  2021cites this paper
• Use and Impact of Positron Emission Tomography/Computed Tomography Prior to Salvage Radiation Therapy in Men with Biochemical Recurrence After Radical Prostatectomy: A Scoping Review.

  2021cites this paper
• Information Needs of Black Prostate Cancer Patients Receiving Treatment Within the South African Public Healthcare System

  2020cites this paper
• Development of a decision support system in oncology for prostate adenocarcinoma

  2020cites this paper
• Magnetic Resonance-guided Stereotactic Radiotherapy for Localized Prostate Cancer: Final Results on Patient-reported Outcomes of a Prospective Phase 2 Study.

  2020cites this paper
• Transperineal ultrasound for aiding target volume delineation and monitoring during prostate cancer radiotherapy in men with bilateral hip prostheses

  2020cites this paper
• Multiparametric and multidimensional: a three-dimensional and multiparametric approach to ultrasound imaging of prostate cancer

  2019cites this paper
• Pelvic Complications After Prostate Cancer Radiation Therapy and Their Management: An International Collaborative Narrative Review.

  2019cites this paper
• Prostate Radiotherapy in India: Evolution, Practice and Challenges in the 21st Century.

  2019cites this paper
• MRI-Based Proton Treatment Planning for Base of Skull Tumors.

  2019cites this paper
• A quality control tool for HDR prostate brachytherapy based on patient-specific geometry and stochastic frontier analysis

  2019cites this paper
• Role of robot‐assisted radical prostatectomy in locally advanced prostate cancer

  2018cites this paper
• Long-term Outcomes of a Dose-reduction Trial to Decrease Late Gastrointestinal Toxicity in Patients with Prostate Cancer Receiving Soft Tissue-matched Image-guided Intensity-modulated Radiotherapy.

  2018cites this paper
• MRI-only based radiation therapy of prostate cancer: workflow and early clinical experience

  2018cites this paper
• Clinical and radiobiological evaluation of a method for planning target volume generation dependent on organ-at-risk exclusions in magnetic resonance imaging-based prostate radiotherapy

  2018cites this paper
• Magnetic Resonance Imaging only Workflow for Radiotherapy Simulation and Planning in Prostate Cancer.

  2018cites this paper
• Late toxicity after post-prostatectomy intensity modulated radiation therapy: Evaluating normal-tissue sparing guidelines

  2018cites this paper
• Intensity-modulated radiotherapy for prostate cancer

  2018cites this paper
• Comparison of Image-Guided Intensity-Modulated Radiotherapy and Low-dose Rate Brachytherapy with or without External Beam Radiotherapy in Patients with Localized Prostate Cancer

  2018cites this paper
• Rectal radiation dose-reduction techniques in prostate cancer: a focus on the rectal spacer.

  2018cites this paper
• Feasibility of MR-only proton dose calculations for prostate cancer radiotherapy using a commercial pseudo-CT generation method

  2017cites this paper
• Evaluation of an automatic MR-based gold fiducial marker localisation method for MR-only prostate radiotherapy

  2017cites this paper
• The evolution of brachytherapy for prostate cancer

  2017cites this paper
• Gene Expression and Fatigue in Puerto Rican Men

  2015cites this paper
• A generative adversarial network approach to synthetic-CT creation for MRI-based radiation therapy

  year unknowncites this paper